New York’s Bristol-Myers Squibb will make over 60 presentations at the forthcoming European Society for Medical Oncology Congress in Madrid, the company says. 31 August 2017
Jazz Pharmaceuticals and ImmunoGen have entered into a global licensing agreement to develop and commercialize two early-stage, hematology-related antibody-drug 29 August 2017
London-listed AstraZeneca has been handed approval from the US Food and Drug Administration to market Faslodex as a monotherapy in breast cancer. 29 August 2017
Japan's Eisai has released data showing a statistically significant improvement in overall survival for patients taking part in the Phase III SELECT trial of ty 29 August 2017
In March 2016, Barack Obama became the first US President to visit Cuba since 1928, marking one of the final stages in a progressive thaw in relations that, it 7 August 2017
The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer space across the eight major markets of the USA, France, Germany, Italy, Spain, 2 August 2017
Merck & Co beat analyst predictions with its second quarter earnings, with soaring sales for the immuno-oncology drug Keytruda (pembrolizumab) proving crucial. 28 July 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.